?-blocker improves survival, left ventricular function, and myocardial remodeling in hypertensive rats with diastolic heart failure
Author(s) -
Makoto Kobayashi,
Noboru Machida,
Mamoru Mitsuishi,
Yasuhiro Yamane
Publication year - 2004
Publication title -
american journal of hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.009
H-Index - 136
eISSN - 1941-7225
pISSN - 0895-7061
DOI - 10.1016/j.amjhyper.2004.07.007
Subject(s) - medicine , heart failure , cardiology , diastole , diastolic function , diastolic heart failure , ventricular remodeling , blood pressure , ejection fraction
Chronic beta-blocker therapy improves survival and left ventricular (LV) systolic function in patients with congestive heart failure. However, its efficacy in diastolic heart failure (DHF) with preserved normal LV systolic function remains uncertain.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom